Who
Ajit Shetty
Director
Company insider
Files Form 4 as: Director, Actinium Pharmaceuticals, Inc. (Delaware); Director, Agile Therapeutics.
In numbers
- Trades disclosed
- 33
- Buys
- 1
- Sells
- 0
- Bought
- $9,774
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 24 Feb 2016
- Last trade
- 2 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 4 Sep 2026 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)Biotechnology | SEC FORM 4 Code A | —61,600 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —92,400 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —92,400 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)Biotechnology | SEC FORM 4 Code A | —61,600 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —2,500 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —2,500 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —8,333 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —8,333 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —18,351 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —72,156 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —70,311 at $0.00 | filing |
| 28 Dec 2023filed 29 Dec 2023 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —70,311 at $0.00 | filing |
| 1 Jul 2022filed 1 Jul 2022 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —72,156 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | Agile Therapeuticsoption or derivative | SEC FORM 4 Code A | —807 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | Agile Therapeutics | SEC FORM 4 Code A | —670 at $0.00 | filing |
| 1 Sep 2021filed 3 Sep 2021 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —18,351 at $0.00 | filing |
| 8 Jun 2021filed 10 Jun 2021 | Agile Therapeutics | SEC FORM 4 Code A | —24,510 at $0.00 | filing |
| 8 Jun 2021filed 10 Jun 2021 | Agile Therapeuticsoption or derivative | SEC FORM 4 Code A | —29,905 at $0.00 | filing |
| 12 Aug 2020filed 14 Aug 2020 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —8,333 at $0.00 | filing |
| 9 Jun 2020filed 11 Jun 2020 | Agile Therapeuticsoption or derivative | SEC FORM 4 Code A | —22,606 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.